Nanobiotix Financials - Benzinga

Nanobiotix SA

NBTXNASDAQ

Trade with Public

Trade with Public

$41.23

-3.93-8.7%

At close: Aug 27, 5:00 PM EST

$45.50

0.340.75%

Pre-Market: 6:52 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Compare Stock Report

Nanobiotix Financials

Nanobiotix (NBTX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
UPDATE: Nanobiotix FY EPS $(0.58) Up From $(1.56) YoY, Sales $37.943M Miss $165.540M Estimate

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 62.82 percent increase over losses of $(1.56) per share from the same period last year. The company reported quarterly sales of $37.943

Benzinga Newsdesk

PRO
Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.58) per share. This is a 137.18 percent decrease over earnings of $1.56 per share from the same period last year. The company reported quarterly sales of $37.943

Benzinga Newsdesk

Earnings Scheduled For March 31, 2026

Benzinga Insights

PRO
Nanobiotix Reports €20.4M In Cash And Cash Equivalents As Of Sept. 30

Benzinga Newsdesk

PRO
Nanobiotix H1 EPS $(0.12) Up From $(0.50) YoY, Sales $30.202M Up From $10.001M YoY

Nanobiotix (NASDAQ:NBTX) reported quarterly losses of $(0.12) per share. This is a 76 percent increase over losses of $(0.50) per share from the same period last year. The company reported $30.202 million in sales this

Benzinga Newsdesk

SelectQuote Posts Better-Than-Expected Results, Joins Nutex Health, NIO, MINISO Group And Other Big Stocks Moving Higher On Thursday

Avi Kapoor